G Dadian

Author PubWeight™ 4.39^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.	Br J Cancer	1998	0.94
2	An analysis of the normal ranges of lymphocyte subpopulations in children aged 5-13 years.	Eur J Pediatr	1996	0.91
3	Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.	Br J Cancer	1995	0.89
4	Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.	Br J Cancer	1992	0.83
5	Plasma neopterin as an adjunct to C-reactive protein in assessment of infection.	Clin Chem	1991	0.82
6	Combined detection of phenotype and Y chromosome by immunoenzyme labelling and in situ hybridisation on peripheral lymphocytes.	J Immunol Methods	1991	0.75
7	The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.	J Pathol	1995	0.75